$77.74
-0.51 (-0.65%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
+111.83%
YTD
+86.03%
Open$78.31
Previous Close$78.25
Day High$80.63
Day Low$76.25
52W High$80.97
52W Low$35.64
Volume—
Avg Volume687.6K
Market Cap6.61B
P/E Ratio—
EPS$-2.70
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$47.74
Above
SMA 200
$36.07
Above
RSI (14)
57.5
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
21 analysts
Price Target
-53.8% upside
Current
$77.74
$77.74
Target
$35.94
$35.94
$23.54
$35.94 avg
$41.91
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 4.63M | 3.43M | 1.61B |
| Net Income | -184,441,650 | -239,151,834 | -285,460,132 |
| Profit Margin | -3,985.0% | -7,343.0% | -17.7% |
| EBITDA | -216,908,907 | -328,687,347 | -344,556,820 |
| Free Cash Flow | — | — | -296,727,069 |
| Rev Growth | +176.6% | -52.1% | +15.2% |
| Debt/Equity | 0.00 | — | 0.66 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $265.21 | +0.28% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $410.24 | +4.34% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $152.67 | +1.40% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $514.99 | +0.84% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $803.90 | +0.72% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $251.65 | +3.00% | 40.0 | 32.33B |